Cas:38168-82-0 3-phospho-D-glyceroyl dihydrogen phosphate manufacturer & supplier

Chemical Name:3-phospho-D-glyceroyl dihydrogen phosphate

CAS.NO:38168-82-0

Synonyms:N’.N’-Di-n-propylsulfanilamide;4-amino-N,N-dipropyl-benzenesulfonamide

Molecular Formula:C₃H₈O₁₀P₂

Molecular Weight:266.03700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:190.44000

Exact Mass:265.95900

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N’.N’-Di-n-propylsulfanilamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-amino-N,N-dipropyl-benzenesulfonamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-amino-N,N-dipropyl-benzenesulfonamide Use and application,4-amino-N,N-dipropyl-benzenesulfonamide technical grade,usp/ep/jp grade.

Related News: This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 3-phospho-D-glyceroyl dihydrogen phosphate manufacturer This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 3-phospho-D-glyceroyl dihydrogen phosphate supplier This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 3-phospho-D-glyceroyl dihydrogen phosphate vendor CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch. 3-phospho-D-glyceroyl dihydrogen phosphate factory CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch.